Related Experiment Video
Updated: Oct 31, 2025

Measuring Volatile and Non-volatile Antifungal Activity of Biocontrol Products
Published on: December 5, 2020
Antifungal drugs work together to treat germs causing fungal infections
Michael A Pfaller1,2, Shawn A Messer2, Lalitagauri M Deshpande2
1University of Iowa, Iowa City, IA, USA.
Abstract:
Life-threatening infections can be caused by a fungus called Candida auris (shortened to C. auris) that is found in the hospital environment. This study looked at how well different drugs could treat C. auris infection. Samples were collected from 36 people who had C. auris infection. The samples were treated with single drugs and in combination. We found that the main drug types did not work on most samples. Genetic differences we found in the C. auris samples could explain why the main drugs did not work. However, a drug called isavuconazole worked on almost all samples. We also found that a drug called anidulafungin worked better against C. auris when it was combined with either isavuconazole or another drug called voriconazole. To read the full Plain Language Summary of this article, click on the View Article button above and download the PDF.
Insights
Most standard antifungal drugs failed against the hospital-acquired fungus Candida auris. Isavuconazole showed high effectiveness, and combinations with anidulafungin improved treatment outcomes for C. auris infections.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Candida auris is an emerging multidrug-resistant fungal pathogen causing severe hospital-associated infections.
- Limited effective treatment options exist for invasive C. auris infections, necessitating the evaluation of novel therapeutic strategies.
Purpose of the Study:
- To assess the in vitro susceptibility of clinical isolates of Candida auris to various antifungal agents.
- To identify effective monotherapy and combination therapy options against C. auris.
Main Methods:
- Antifungal susceptibility testing was performed on 36 clinical isolates of Candida auris.
- Isolates were treated with single antifungal drugs and combinations, including echinocandins, azoles, and isavuconazole.
- Genetic analysis was conducted to explore potential correlations between resistance mechanisms and drug efficacy.
Main Results:
- Most tested isolates exhibited resistance to commonly used antifungal drugs.
- Isavuconazole demonstrated potent activity against nearly all C. auris isolates.
- Combination therapy of anidulafungin with isavuconazole or voriconazole showed enhanced efficacy compared to monotherapy.
Conclusions:
- Isavuconazole represents a promising therapeutic agent for treating Candida auris infections.
- Combination antifungal therapies may be crucial for overcoming resistance and improving treatment outcomes in invasive C. auris disease.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Antimicrobial Effectiveness
Chemical Agents for Microbial Control
Overview of Fungi
Fungal Group Zygomycota

